| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.27221 |
| P698 | PubMed publication ID | 24825302 |
| P2093 | author name string | Hao Yang | |
| Feng Fang | |||
| Lian-Yue Yang | |||
| Jiang-Feng Xu | |||
| Rui-Min Chang | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis | Q24316200 | ||
| Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis | Q24632198 | ||
| PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma | Q28115966 | ||
| Biology of hepatocellular carcinoma | Q28266656 | ||
| Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma | Q28273449 | ||
| Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer | Q28530422 | ||
| Hepatocellular carcinoma | Q29615765 | ||
| miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer | Q34117962 | ||
| miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia | Q34700780 | ||
| miR-331-3p regulates expression of neuropilin-2 in glioblastoma | Q35021427 | ||
| Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression | Q35223274 | ||
| A decade's studies on metastasis of hepatocellular carcinoma | Q35611503 | ||
| The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells | Q35842164 | ||
| The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. | Q35983641 | ||
| Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells | Q36318823 | ||
| Molecular mechanisms of hepatocellular carcinoma | Q37323726 | ||
| miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer | Q37375623 | ||
| MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? | Q38053397 | ||
| SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition | Q39169788 | ||
| Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma | Q39181475 | ||
| MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. | Q39184127 | ||
| MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma | Q39196206 | ||
| MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways | Q39240312 | ||
| Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation | Q40124678 | ||
| Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL). | Q43223918 | ||
| MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway | Q47616223 | ||
| Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. | Q47821487 | ||
| Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 | ||
| Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. | Q54252991 | ||
| Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo. | Q54343391 | ||
| Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma | Q61645725 | ||
| Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection | Q83078350 | ||
| MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression | Q84598420 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 1251-1263 | |
| P577 | publication date | 2014-08-21 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase | |
| P478 | volume | 60 |
| Q57493806 | A miRNA Combination as Promising Biomarker for Hepatocellular Carcinoma Diagnosis: A Study Based on Bioinformatics Analysis |
| Q38859488 | Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review) |
| Q36562108 | Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma |
| Q34506340 | Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition |
| Q93060759 | An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma |
| Q89224112 | Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1 |
| Q35865032 | Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model. |
| Q37472263 | Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison |
| Q42371643 | Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles |
| Q64057860 | Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer |
| Q35552063 | Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma |
| Q26749533 | Clinical significance of microRNAs in chronic and acute human leukemia |
| Q90227068 | DNA Methylation and Micro-RNAs: The Most Recent and Relevant Biomarkers in the Early Diagnosis of Hepatocellular Carcinoma |
| Q88726117 | DNA methylation and FoxO3a regulate PHLPP1 expression in chondrocytes |
| Q52673512 | Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling. |
| Q41081103 | Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. |
| Q64942973 | Exosomes in the Oncobiology, Diagnosis, and Therapy of Hepatic Carcinoma: A New Player of an Old Game. |
| Q38728270 | Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line. |
| Q26784412 | Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma |
| Q50280266 | Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo |
| Q64094459 | Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer |
| Q37457852 | JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling |
| Q58778589 | LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p |
| Q91828982 | Long Non-Coding RNA NEAT1 Promoted Hepatocellular Carcinoma Cell Proliferation and Reduced Apoptosis Through the Regulation of Let-7b-IGF-1R Axis |
| Q92068468 | Long Noncoding RNA KCNQ1OT1 Promotes the Progression of Non-Small Cell Lung Cancer via Regulating miR-204-5p/ATG3 Axis |
| Q36023541 | Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2 |
| Q38823802 | MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development |
| Q39472499 | MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma |
| Q38917852 | MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3. |
| Q36729381 | MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma |
| Q88122807 | MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic R |
| Q38795326 | MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling |
| Q37010976 | MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression |
| Q35955257 | MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. |
| Q52671332 | MicroRNA-331 inhibits proliferation and invasion of melanoma cells by targeting astrocyte-elevated gene-1. |
| Q37210229 | MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2 |
| Q92899935 | MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer |
| Q36413892 | MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma |
| Q58804590 | MicroRNA-506 suppresses invasiveness and metastasis of human hepatocellular carcinoma cells by targeting |
| Q36571466 | MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma |
| Q38827376 | MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor |
| Q92286998 | MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance |
| Q38541359 | Non-Coding RNAs in Primary Liver Cancer |
| Q36232052 | Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma |
| Q38664551 | PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases |
| Q39027993 | PHLPPing through history: a decade in the life of PHLPP phosphatases |
| Q46874998 | Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C. |
| Q47096853 | Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis |
| Q38647185 | Role of Forkhead Box Class O proteins in cancer progression and metastasis |
| Q61817967 | Role of FoxO Proteins in Cellular Response to Antitumor Agents |
| Q52694945 | STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma. |
| Q37518963 | Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma |
| Q53531177 | Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. |
| Q58726258 | Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma |
| Q91940241 | Significant role and mechanism of microRNA-143-3p/KLLN axis in the development of coronary heart disease |
| Q55401749 | Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. |
| Q35856250 | Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation |
| Q38844891 | Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer |
| Q92313741 | The Effect of MicroRNA-331-3p on Preadipocytes Proliferation and Differentiation and Fatty Acid Accumulation in Laiwu Pigs |
| Q35740131 | The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells |
| Q55024083 | The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target. |
| Q54998576 | The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma. |
| Q37694682 | The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer |
| Q38937821 | The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma |
| Q36545975 | Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. |
| Q37688277 | YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma |
| Q49209465 | miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway |
| Q50130129 | miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma |
| Q36545884 | miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F |
| Q59329806 | miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling |
| Q92959100 | miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway |
| Q90341931 | miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2 |
| Q36741105 | miR-517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer |
| Q38300178 | miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5. |
| Q34795479 | microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1 |
| Q92605964 | microRNA-27a-3p Down-regulation Inhibits Malignant Biological Behaviors of Ovarian Cancer by Targeting BTG1 |
Search more.